BalanceNCT04775342
Smartphone and Posture Control In Healthy Adolescents
An observational study of Balance, run by Cairo University at 1 site in Egypt.
Trial summary
This is a study to determine if smartphone use affect posture control in adolescents. Read more about this study
- Who is it for?
- Ages 14 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Balance
- What is being tested?
- smartphone
- Type of treatment
- Medical device
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 12 Apr 2021to 27 Nov 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: Normal Adolescents
Who may be able to join
- Children age from 14 to 18 years old.
- Both genders will be included.
- Normal Body mass index (BMI) for age.
- Children using smartphone for at least 1 year.
Who cannot join
- Obese children.
- children with vestibular or visual problems.
- Children with neurological disorders.
- Children with congenital deformities or musculoskeletal disorders.
- Children with cognitive impairment.
- Injuries or inflammatory conditions involving the extremities.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Smartphone Dual Tasking and Posture Control In Healthy Adolescents
This is a study to determine if smartphone use affect posture control in adolescents.
Read the detailed description
It is within subject repeated measure study to determine if touch screen use affect posture control in healthy adolescents.
200 normal adolescents between 14 and 18 years old will be included.
1st they will be assessed for posture control to determine normal values for their ages, then each child will be given smartphone to play a game while the sound is muted for 15 min then their balance will be re-assessed, finally they will use the phone for another 15 min but the children will use headphone piece this time then re-assess balance.
- Conditions
- Balance
- Being tested
- smartphone
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
smartphoneDevice
Also called touch screen
modern technology
| Study group | Role | What they receive |
|---|---|---|
| 1 group | 1 group will be assessed then will be given smartphone to use and assessed Receives: Device: smartphone |
What is being measured
The primary outcome is the main question the study is designed to answer.
center of pressure
a metric for measuring changes in posture control
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Mar 2021
- Study start12 Apr 2021
- Primary completion2 Jul 2021
- Study completion27 Nov 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BalanceStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esraa Abd Elaziz Anter, Cairo University
- Investigators
- Amira M Eltohamy, Study chair, professor at Cairo university
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04775342
- Sponsor's protocol ID
- smartphone and adolescents
- Status last verified
- May 2022
- First submitted
- 25 Feb 2021
- Last updated
- 24 May 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Smartphone Dual Tasking and Posture Control In Healthy Adolescents
- ClinicalTrials.gov ID
- NCT04775342
- Acronym / sponsor ID
- smartphone and adolescents
- Conditions
- Balance
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 12 Apr 2021 (actual)
- Primary completion
- 2 Jul 2021 (actual)
- Study completion
- 27 Nov 2021 (actual)
- First posted
- 1 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a study to determine if smartphone use affect posture control in adolescents.
Detailed description
It is within subject repeated measure study to determine if touch screen use affect posture control in healthy adolescents.
200 normal adolescents between 14 and 18 years old will be included.
1st they will be assessed for posture control to determine normal values for their ages, then each child will be given smartphone to play a game while the sound is muted for 15 min then their balance will be re-assessed, finally they will use the phone for another 15 min but the children will use headphone piece this time then re-assess balance.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 group | – | Device: smartphone1 group will be assessed then will be given smartphone to use and assessed |
Who may qualify
- Ages
- 14 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Normal Adolescents
Key inclusion criteria (4 listed)
- Children age from 14 to 18 years old.
- Both genders will be included.
- Normal Body mass index (BMI) for age.
- Children using smartphone for at least 1 year.
Key exclusion criteria (6 listed)
- Obese children.
- children with vestibular or visual problems.
- Children with neurological disorders.
- Children with congenital deformities or musculoskeletal disorders.
- Children with cognitive impairment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| smartphoneAlso: touch screenmodern technology | Device | 1 group |
Primary outcome
center of pressure
Time frame: 6 months
a metric for measuring changes in posture control
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 May 2022.
Related trials for Balance
Not yet recruiting
Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b
Chronic Kidney Disease Stage 3A, Chronic Kidney Disease Stage 3B
Not yet recruitingObservational study
Serum Treg/Th17-Related Cytokines and Systemic Inflammatory Indices in Differentiated Thyroid Cancer
Differentiated Thyroid Cancer (DTC), Papillary Thyroid Carcinoma
RecruitingPhase 1/2
Stimulation-based Therapy to Improve Balance in DCM
Degenerative Cervical Myelopathy
RecruitingPhase 1
Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Recruiting
Stress Modulation and Dynamic Balance
Stress
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amira M Eltohamy study chair
professor at Cairo university
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Balance, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
center of pressure (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2022.